Pembro + CRT in HNSCC fails to deliver statistically significant event-free survival improvement
Pembro + CRT in HNSCC fails to deliver statistically significant event-free survival improvement
New era of early cancer detection blood tests on the horizon
Hyperthermic intraperitoneal chemo for locally advanced colon cancer
HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan
Extended adjuvant AI not advised for HPBC after 5+ yrs of sequential endocrine therapy
Olaparib continues to show positive results in advanced ovarian cancer - 7 year data
How air pollution may trigger lung cancer in never-smokers
Tumour-infiltrating lymphocyte treatment for advanced melanoma
Nirogacestat success for desmoid tumours
OncoAlert and ecancer weekly round up for August 15th - 21st, 2022
OncoAlert and ecancer weekly round up for August 8th - 14th, 2022
Global obstacles to lung cancer screening: Report